Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models? (English)
- New search for: Chargari, C.
- New search for: Goodman, K. A.
- New search for: Diallo, I.
- New search for: Guy, J. B.
- New search for: Rancoule, C.
- New search for: Cosset, J. M.
- New search for: Deutsch, E.
- New search for: Magne, N.
- New search for: Chargari, C.
- New search for: Goodman, K. A.
- New search for: Diallo, I.
- New search for: Guy, J. B.
- New search for: Rancoule, C.
- New search for: Cosset, J. M.
- New search for: Deutsch, E.
- New search for: Magne, N.
In:
CANCER AND METASTASIS REVIEWS
;
35
, 2
;
277-288
;
2016
-
ISSN:
- Article (Journal) / Print
-
Title:Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?
-
Contributors:Chargari, C. ( author ) / Goodman, K. A. ( author ) / Diallo, I. ( author ) / Guy, J. B. ( author ) / Rancoule, C. ( author ) / Cosset, J. M. ( author ) / Deutsch, E. ( author ) / Magne, N. ( author )
-
Published in:CANCER AND METASTASIS REVIEWS ; 35, 2 ; 277-288
-
Publisher:
- New search for: Springer Science + Business Media
-
Place of publication:Springer Science + Business Media
-
Publication date:2016-01-01
-
Size:12 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 35, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 151
-
The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcomaLiao, Y. / Feng, Y. / Shen, J. / Hornicek, F. J. / Duan, Z. et al. | 2016
- 165
-
The promising alliance of anti-cancer electrochemotherapy with immunotherapyCalvet, C. Y. / Mir, L. M. et al. | 2016
- 179
-
Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biologyGoel, R. K. / Lukong, K. E. et al. | 2016
- 201
-
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancerLiu, W. / Rodgers, G. P. et al. | 2016
- 213
-
Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasisWojtukiewicz, M. Z. / Hempel, D. / Sierko, E. / Tucker, S. C. / Honn, K. V. et al. | 2016
- 235
-
Deciphering the function of non-coding RNAs in prostate cancerRamalho-Carvalho, J. o. / Fromm, B. / Henrique, R. / Jerónimo, C. et al. | 2016
- 263
-
Genomics of gallbladder cancer: the case for biomarker-driven clinical trial designSicklick, J. K. / Fanta, P. T. / Shimabukuro, K. / Kurzrock, R. et al. | 2016
- 277
-
Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?Chargari, C. / Goodman, K. A. / Diallo, I. / Guy, J. B. / Rancoule, C. / Cosset, J. M. / Deutsch, E. / Magne, N. et al. | 2016
- 289
-
miR clusters target cellular functional complexes by defining their degree of regulatory freedomHaier, J. r. / Ströse, A. / Matuszcak, C. / Hummel, R. et al. | 2016
- 323
-
Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastasesLiu, M. C. / Cortés, J. / O’Shaughnessy, J. et al. | 2016
- 333
-
Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis managementNakajima, K. / Kho, D. H. / Yanagawa, T. / Zimel, M. / Heath, E. / Hogan, V. / Raz, A. et al. | 2016